2,2,2-Trifluoroethyl N-(2-oxo-2H-chromen-6-yl)carbamate

Catalog No. :
ACXCQG393
CAS No. :
1354961-77-5
Molecular Formula :
C12H8F3NO4
Molecular Weight :
287.19

IUPAC Name:2,2,2-trifluoroethyl (2-oxo-2H-chromen-6-yl)carbamate

2,2,2-Trifluoroethyl N-(2-oxo-2H-chromen-6-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$308.00Login to see priceInquiryInquiry
250mg95%$431.00Login to see priceInquiryInquiry
1g95%$855.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,2,2-Trifluoroethyl N-(2-oxo-2H-chromen-6-yl)carbamate
IUPAC Name2,2,2-trifluoroethyl (2-oxo-2H-chromen-6-yl)carbamate
MDL No.MFCD20501891
Molecular FormulaC12H8F3NO4
Molecular Weight287.19
SMILESO=C(OCC(F)(F)F)NC1=CC(C=CC2=O)=C(O2)C=C1
InChI KeyPBRDJMLJYQJFHV-UHFFFAOYSA-N
Synonym2,2,2-trifluoroethyl N-(2-oxo-2H-chromen-6-yl)carbamate;Carbamic acid, N-(2-oxo-2H-1-benzopyran-6-yl)-, 2,2,2-trifluoroethyl ester;2,2,2-Trifluoroethyl N-(2-oxo-2H-1-benzopyran-6-yl)carbamate
CAS No.1354961-77-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACXCQG393 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMOAZ901 route compound structure diagram
    ACMOAZ90114415-44-2 In Stock
  2. Plus
  3. ACCDJG914 route compound structure diagram
    ACCDJG91427746-99-2 In Stock
  4. Then
  5. ACXCQG393 route product structure diagram
    ACXCQG3931354961-77-5
Inquiry

2. ACXCQG393 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXCQG393 route product structure diagram
    ACXCQG3931354961-77-5
Inquiry

Comments (0)